Literature DB >> 11870586

Glial fibrillary acidic protein and neurofilament in children with cerebral white matter abnormalities.

R Kristjánsdóttir1, P Uvebrant, L Rosengren.   

Abstract

Glial fibrillary acidic protein (GFAP) is the major structural protein of the intermediate filaments found in glial cells. Increased levels in the cerebrospinal fluid (CSF) have been found to indicate gliosis. Neurofilament (NFL) is a structural element of neurons, mainly found in large myelinated axons. Its presence in the CSF has been suggested to reflect destruction of axons. The aim of this study was to see if GFAP and NFL in the CSF of children with neurological disabilities and an abnormal signal on magnetic resonance imaging (MRI) of the cerebral white matter could be used to clarify the underlying neuropathology. The potential of GFAP and NFL to differentiate a progressive disease from a stationary disorder was investigated, as was the correlation with disability and clinical findings. CSF from 26 children, eleven with progressive and 15 with non-progressive disorders, was analysed. GFAP was increased in all, interpreted to reflect gliosis. NFL was elevated in seven and considered to indicate ongoing neuroaxonal damage as all but one patient were found to have a progressive disease. GFAP did not differentiate between progressive and non-progressive disorders, although low levels were found in stationary and high levels in progressive disorders. The severity of the disability correlated with the NFL levels, but not with the concentration of GFAP.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11870586     DOI: 10.1055/s-2001-20406

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  5 in total

1.  Serum neurofilament light chain is a useful biomarker in pediatric multiple sclerosis.

Authors:  Marie-Christine Reinert; Pascal Benkert; Jens Wuerfel; Zuzanna Michalak; Esther Ruberte; Christian Barro; Peter Huppke; Wiebke Stark; Harald Kropshofer; Davorka Tomic; David Leppert; Jens Kuhle; Wolfgang Brück; Jutta Gärtner
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2020-05-13

2.  Prognostic plasma exosomal microRNA biomarkers in patients with substance use disorders presenting comorbid with anxiety and depression.

Authors:  Fengrong Chen; Lei Zou; Yicong Dai; Jiaxue Sun; Cheng Chen; Yongjin Zhang; Qingyan Peng; Zunyue Zhang; Zhenrong Xie; Hongjin Wu; Weiwei Tian; Xu Yu; Juehua Yu; Kunhua Wang
Journal:  Sci Rep       Date:  2021-03-18       Impact factor: 4.379

3.  Cerebrospinal fluid biomarkers in various pediatric neurologic diseases.

Authors:  Jeongho Lee
Journal:  Clin Exp Pediatr       Date:  2022-01-06

4.  Label-free mass spectrometric analysis reveals complex changes in the brain proteome from the mdx-4cv mouse model of Duchenne muscular dystrophy.

Authors:  Sandra Murphy; Margit Zweyer; Michael Henry; Paula Meleady; Rustam R Mundegar; Dieter Swandulla; Kay Ohlendieck
Journal:  Clin Proteomics       Date:  2015-11-23       Impact factor: 3.988

5.  Promising candidate cerebrospinal fluid biomarkers of seizure disorder, infection, inflammation, tumor, and traumatic brain injury in pediatric patients.

Authors:  Seh Hyun Kim; Soo Ahn Chae
Journal:  Clin Exp Pediatr       Date:  2021-08-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.